These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12141412)

  • 21. Thrombotic thrombocytopenic purpura associated with everolimus use in a renal transplant patient.
    Yılmaz VT; Koçak H; Avcı AB; Salim O; Ersoy FF; Süleymanlar G
    Int Urol Nephrol; 2011 Jun; 43(2):581-4. PubMed ID: 20495869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful retransplantation using rapamycin in a patient with previous calcineurin inhibitor-induced posterior leukoencephalopathy syndrome.
    Afzali B; Goldsmith DJ
    Clin Nephrol; 2003 Mar; 59(3):225-8. PubMed ID: 12653269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombotic microangiopathy after simultaneous pancreas-kidney transplantation.
    Rangel EB; Gonzalez AM; Linhares MM; Araújo SR; Franco MF; de Sá JR; Pestana JO; Melaragno CS
    Clin Transplant; 2007; 21(2):241-5. PubMed ID: 17425752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current immunosuppressive agents in pediatric renal transplantation: efficacy, side-effects and utilization.
    Smith JM; Nemeth TL; McDonald RA
    Pediatr Transplant; 2004 Oct; 8(5):445-53. PubMed ID: 15367279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Association of everolimus with tacrolimus during the first year after heart transplantation: initial experience].
    Cardona M; Castel MÁ; Farrero M; Pérez-Villa F
    Med Clin (Barc); 2013 Jul; 141(2):87-8. PubMed ID: 23384432
    [No Abstract]   [Full Text] [Related]  

  • 26. Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature.
    Shapiro R; Scantlebury VP; Jordan ML; Vivas C; Gritsch HA; McCauley J; Fung JJ; Hakala TR; Simmons RL; Starzl TE
    Transplant Proc; 1997 Sep; 29(6):2737-8. PubMed ID: 9290809
    [No Abstract]   [Full Text] [Related]  

  • 27. Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence.
    Pizzo HP; Ettenger RB; Gjertson DW; Reed EF; Zhang J; Gritsch HA; Tsai EW
    Pediatr Nephrol; 2016 Dec; 31(12):2345-2352. PubMed ID: 27286686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comment: delayed wound healing with sirolimus after liver transplant.
    Mathis AS
    Ann Pharmacother; 2003 Mar; 37(3):453. PubMed ID: 12639183
    [No Abstract]   [Full Text] [Related]  

  • 29. Balancing efficacy and toxicity in kidney-transplant immunosuppression.
    Leichtman AB
    N Engl J Med; 2007 Dec; 357(25):2625-7. PubMed ID: 18094383
    [No Abstract]   [Full Text] [Related]  

  • 30. Measuring adherence to medications: are complex methods superior to simple ones?
    Shemesh E
    Pediatr Transplant; 2012 Jun; 16(4):315-7. PubMed ID: 22452614
    [No Abstract]   [Full Text] [Related]  

  • 31. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tacrolimus (FK-506) in kidney transplantation.
    Shapiro R
    Transplant Proc; 1997; 29(1-2):45-7. PubMed ID: 9123077
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens.
    Felix MJ; Felipe CR; Tedesco-Silva H; Osmar Medina-Pestana J
    Pharmacotherapy; 2016 Feb; 36(2):152-65. PubMed ID: 26799522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary alveolar proteinosis in a kidney transplant: a rare complication of sirolimus.
    Kadikoy H; Paolini M; Achkar K; Suki W; Gaber AO; Anwar N; Jeroudi A; Barrios R; Abdellatif A
    Nephrol Dial Transplant; 2010 Aug; 25(8):2795-8. PubMed ID: 20484303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK.
    McEwan P; Dixon S; Baboolal K; Conway P; Currie CJ
    Pharmacoeconomics; 2006; 24(1):67-79. PubMed ID: 16445304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of ileal ulcers caused by immunosuppressants in two organ transplant recipients.
    Guo YW; Gu HY; Abassa KK; Lin XY; Wei XQ
    World J Gastroenterol; 2016 Jun; 22(24):5616-22. PubMed ID: 27350740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirolimus in pediatric patients: results in the first 6 months post-renal transplant.
    Hymes LC; Warshaw BL
    Pediatr Transplant; 2005 Aug; 9(4):520-2. PubMed ID: 16048606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rescue therapy with sirolimus in a renal transplant recipient with tacrolimus-induced hepatotoxicity.
    Mesar I; Kes P; Hudolin T; Basic-Jukic N
    Ren Fail; 2013; 35(10):1434-5. PubMed ID: 24028307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Von Willebrand factor--cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: a case report.
    Nakazawa Y; Hashikura Y; Urata K; Ikegami T; Terada M; Yagi H; Ishizashi H; Matsumoto M; Fujimura Y; Miyagawa S
    Liver Transpl; 2003 Dec; 9(12):1328-33. PubMed ID: 14625834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.